The private placement works out to 2.7 million shares at $2.50 per share. Following the completion of this second investment, Evotec’s total investment in Sernova is $27 million, according to a Sept. 1 Sernova news release.
Sernova will use the latest funding for general working capital and to continue work on drugs to treat diabetes, hypothyroidism and hemophilia A.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
